The Native Antigen Company (NAC) is an Oxford-based contract service provider specialising in the R&D and scale-up manufacturing of highly pure viral and bacterial native antigens. NAC's antigens are used primarily by pharmaceutical and IVD manufacturers in vaccine research and serology where high specificity and sensitivity are vital. As well as offering antigens from a rapidly expanding portfolio, NAC undertakes bespoke product development and partnering.
NAC's scientific team operates from a well-equipped laboratory located at the Cherwell Innovation Centre in Oxfordshire. NAC is ISO 9001:2008 accredited.